@ARTICLE{
author={Andreas AP,Boskovic Darinka V,Gastl Guenther A},
year={2008},
title={High Doses Of Imatinib Mesylate (800mg/Day) Significantly Improve Rates Of Major And Complete Cytogenetic Remissions (Mcr, Ccr) - Results From The First Planned Interim Analysis Of A Multicenter, Randomised, 2-Arm - Phase Iii Study Comparing Imatinib Standard Dose (400 Mg/Day) With Imatinib High Do},
journal={HAEMATOLOGICA-THE HEMATOLOGY JOURNAL},
volume={93},
number={},
pages={0406-},
document_type={Meeting Abstract},
}